Improper Drug Promotion Analysis

The number of complaints due to faulty drug promotion was very close in both countries; specifically, 933 complaints were registered in the UK and 916 in Sweden (see figure 2). It is worthy to note that both countries were registering more than one complaint per week due to improper drug promotion. Out of the 933 complaints in the UK, 110 complaints were considered serious violations (11.8%); furthermore, there were 916 complaints in Sweden of which 101 complaints were serious violations (see figure 2). In addition, it is worthy to note that a large number of serious violations in both countries stemmed from drug promotion for diabetes and urology drug products. The ability to identify, monitor and track misrepresentation was due to regulatory agencies from both countries following active monitoring. Both regulatory bodies stated that this number of violations is very high for an industry with its own regulatory system and a solid stance needs to be taken regarding drug promotion practices. …show more content…
Serious violations reveal that misrepresentation of information to the public can compromise patient safety by changing prescribing practices of doctors; furthermore, companies can go even further by manipulating the drug regulatory system in order to seek approval for a new